Illumina Reagents and Consumables.

Awarded Limited / Sole Source Justification Posted

Solicitation number
75N92020D00022-P00003
Agency
Set-aside
No set-aside

Opportunity facts

Contract number
75N92020D00022 Federal IDV award
Awardee
Illumina, Inc.
Place of performance
San Diego, California 92122, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Heart, Lung and Blood Institute, part of the Department of Health and Human Services' National Institutes of Health, has issued a sole source justification for the extension of an existing contract with Illumina, Inc. for specialized reagents and consumables. The contract modification extends the Indefinite Delivery, Indefinite Quantity (IDIQ) agreement from September 3, 2020 through March 2, 2026, with a total maximum contract value of $92,416,478. The sole source justification is based on the proprietary nature of Illumina's reagents and consumables, which are specifically designed to operate the NIH's 201 Illumina sequencing and genotyping systems valued at over $57 million. The agency determined that these specialized reagents cannot be substituted with products from other manufacturers without compromising research integrity and the functionality of existing equipment. The contract will enable the NIH to procure reagents and consumables for various Illumina sequencing platforms, including NovaSeq X Plus, NovaSeq 6000, NextSeq 1000/2000, and MiSeq systems, which are essential for ongoing genomic research and experimental replication. Market research conducted by the NIH identified no alternative sources, and no other vendors responded to the notice of intent to award the contract modification.

Notice text

The purpose of this announcement is to post a redacted Justification for Other than Full and Open Competition for 30 Days in accordance with FAR Part 6.305.

Awarded contract 75N92020D00022 to unknown vendor for unknown amount on 2025-06-26.

Files

File Type Posted
4RS JOTFOC-pop-extension-final_edited_BB_Redacted.pdf PDF

Similar open opportunities

Opportunity Agency Set-aside Responses due
1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) Bethesda, Maryland 20892, United States · NAICS 811210 National Institute of Allergy and Infectious Diseases No set-aside
NOI - DNA Sequencing of Bone Marrow Failure Syndro NAICS 325413 Office of Logisitics and Acquisition Operations No set-aside
Notice of Intent to Sole Source – AB Sciex LLC Maryland 20892, United States · NAICS 339112 NIH Clinical Center No set-aside
Comprehensive full-service maintenance/repair plan for Illumina Nova/Seq 6000 Frederick, Maryland 21702, United States · NAICS 334516 Naval Supply Systems Command No set-aside
Comprehensive full-service maintenance/repair plan for Illumina Nova/Seq 6000 Silver Spring, Maryland 20910, United States · NAICS 811210 Naval Supply Systems Command No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity